[go: up one dir, main page]

WO2009128631A3 - Procédé de préparation d'une α-glycérophosphorylcholine racémique ou optiquement active et d'un dérivé de cette dernière - Google Patents

Procédé de préparation d'une α-glycérophosphorylcholine racémique ou optiquement active et d'un dérivé de cette dernière Download PDF

Info

Publication number
WO2009128631A3
WO2009128631A3 PCT/KR2009/001894 KR2009001894W WO2009128631A3 WO 2009128631 A3 WO2009128631 A3 WO 2009128631A3 KR 2009001894 W KR2009001894 W KR 2009001894W WO 2009128631 A3 WO2009128631 A3 WO 2009128631A3
Authority
WO
WIPO (PCT)
Prior art keywords
derivative
glycerophosphorylcholine
optically active
racemic
aqueous solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2009/001894
Other languages
English (en)
Korean (ko)
Other versions
WO2009128631A2 (fr
Inventor
황순욱
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of WO2009128631A2 publication Critical patent/WO2009128631A2/fr
Publication of WO2009128631A3 publication Critical patent/WO2009128631A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/10—Phosphatides, e.g. lecithin
    • C07F9/106—Adducts, complexes, salts of phosphatides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/113—Esters of phosphoric acids with unsaturated acyclic alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A61K31/6615—Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/65515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/6574—Esters of oxyacids of phosphorus
    • C07F9/65742—Esters of oxyacids of phosphorus non-condensed with carbocyclic rings or heterocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

L'invention porte sur un nouveau procédé de préparation d'une D ou L-α-glycérophosphorylcholine racémique ou optiquement active et d'un dérivé de cette dernière possédant d'excellents effets thérapeutiques sur les symptômes secondaires entraînés par une attaque cérébrovasculaire et par le syndrome encéphalique organique dégénératif. En particulier, l'invention se rapporte à un procédé économique permettant une production massive de la D ou L-α-glycérophosphorylcholine racémique ou optiquement active et de son dérivé, avec un niveau de pureté et un rendement élevés. Le procédé selon l'invention permet de provoquer une réaction d'ouverture de cycle d'un (S) or (R)-glycidol racémique facultativement de grande pureté et d'un dérivé de ce dernier, en faisant appel à de la choline phosphate comme matière de départ dans une solution à température ambiante, et en utilisant ensuite des bases inorganiques ou des acides de Lewis pour augmenter la vitesse de réaction dans la solution.
PCT/KR2009/001894 2008-04-15 2009-04-14 Procédé de préparation d'une α-glycérophosphorylcholine racémique ou optiquement active et d'un dérivé de cette dernière Ceased WO2009128631A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2008-0034490 2008-04-15
KR1020080034490A KR100951108B1 (ko) 2008-04-15 2008-04-15 라세믹 또는 광학적으로 활성이 있는 α-글리세로포스포릴콜린 및 그 유도체의 제조방법

Publications (2)

Publication Number Publication Date
WO2009128631A2 WO2009128631A2 (fr) 2009-10-22
WO2009128631A3 true WO2009128631A3 (fr) 2010-01-21

Family

ID=41199557

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2009/001894 Ceased WO2009128631A2 (fr) 2008-04-15 2009-04-14 Procédé de préparation d'une α-glycérophosphorylcholine racémique ou optiquement active et d'un dérivé de cette dernière

Country Status (2)

Country Link
KR (1) KR100951108B1 (fr)
WO (1) WO2009128631A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101330814B1 (ko) * 2009-12-10 2013-11-15 주식회사 한서켐 콜린 알포세레이트의 제조방법
KR101233138B1 (ko) * 2012-11-06 2013-02-22 주식회사 한서켐 L-α-글리세릴 포스포릴 콜린의 제조방법
CN103304594B (zh) * 2013-06-18 2015-07-08 上海科利生物医药有限公司 一种L-α-甘油磷酸胆碱的制备方法
KR20230023339A (ko) 2021-08-10 2023-02-17 스마트바이오팜 주식회사 연속흐름공정을 이용하여 콜린알포세레이트를 제조하는 방법
CN114478622A (zh) * 2022-03-17 2022-05-13 沈阳金久奇科技有限公司 一种磷脂酰胆碱的制备方法
KR20240124730A (ko) 2023-02-09 2024-08-19 스마트바이오팜 주식회사 연속흐름공정을 이용하여 콜린알포세레이트를 제조하는 방법

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4610979A (en) * 1983-03-05 1986-09-09 A. Nattermann & Cie Gmbh O-acyl-alkanediol-phospholipids and processes for the treatment of asthma
KR19990064281A (ko) * 1995-10-16 1999-07-26 존 바드웰 중합성 포스포디에스테르의 합성방법
KR20070119176A (ko) * 2006-06-14 2007-12-20 주식회사 대웅제약 Ｌ-α-글리세로포스포릴 콜린의 제조방법

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1245736B (it) 1990-11-15 1994-10-14 Magis Farmaceutici Processo per preparare alfa-glicerofosforilcolina

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4610979A (en) * 1983-03-05 1986-09-09 A. Nattermann & Cie Gmbh O-acyl-alkanediol-phospholipids and processes for the treatment of asthma
KR19990064281A (ko) * 1995-10-16 1999-07-26 존 바드웰 중합성 포스포디에스테르의 합성방법
KR20070119176A (ko) * 2006-06-14 2007-12-20 주식회사 대웅제약 Ｌ-α-글리세로포스포릴 콜린의 제조방법

Also Published As

Publication number Publication date
WO2009128631A2 (fr) 2009-10-22
KR100951108B1 (ko) 2010-04-07
KR20090109172A (ko) 2009-10-20

Similar Documents

Publication Publication Date Title
IN2014CN03466A (fr)
WO2009128631A3 (fr) Procédé de préparation d'une α-glycérophosphorylcholine racémique ou optiquement active et d'un dérivé de cette dernière
PE20141160A1 (es) Metodos para preparar analogos nucleotidicos antivirales
WO2009102155A3 (fr) Processus de préparation de dérivés d'acide 2-méthyl-2´-phénylpropionique et nouveaux composés intermédiaires
IN2014CN00989A (fr)
WO2011087316A3 (fr) Procédé pour préparer des sels d'acide tétrazole-méthanesulfonique, et nouveau composé utilisé dans celui-ci
WO2012025944A3 (fr) Sitagliptine, sels et polymorphes de celle-ci
AR062092A1 (es) Proceso para la fabricacion de diesteres
BR112014014762A2 (pt) método para preparação de cisteína ou de um derivado desta usando uma nova o-fosferina sulfidrilase
UA101835C2 (uk) Спосіб отримання похідних 1-(2-галогенбіфеніл-4-іл)-циклопропанкарбонової кислоти
MY164880A (en) Process for the preparation of isoxazolyl-methoxy-nicotinic acids
WO2014003203A3 (fr) Procédé de production d'un composé époxycétone stéréosélectif
WO2012093411A3 (fr) Méthode de préparation d'acide r-(-)-3-(carbamoylméthyl)-5-méthylhexanoïque et de ses intermédiaires
WO2011102640A3 (fr) Procédé de préparation de sitagliptine et sels d'amines intermédiaires utilisés dans ce procédé
MX2010009926A (es) Nuevo proceso para la preparacion de derivados de acido ciclohexancarboxilico.
WO2012115402A3 (fr) Forme cristalline du docétaxel et procédé de préparation associé
EA200870320A1 (ru) Способ получения г-ксф человека
WO2010097802A3 (fr) Procédé de préparation d'étoricoxib
MX338556B (es) Metodos para aislar acidos 4-cloro-2-fluoro-3-fenilboronicos sustituidos.
WO2013072938A3 (fr) Procédé amélioré pour la préparation de roflumilast
WO2013046233A3 (fr) Procédé de préparation d'acétate d'octréotide
WO2012059680A3 (fr) Procédé de préparation d'imides cycliques, de leurs dérivés et utilisations
WO2011157670A3 (fr) Nouveau procédé
WO2012081036A3 (fr) Procédé de préparation de 4,4'-(1-méthyl-1,2-éthanediyl)-bis-(2,6-pipérazinedione)
WO2008142097A3 (fr) Procédé de fabrication de composés à terminaison carbonate

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09732800

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09732800

Country of ref document: EP

Kind code of ref document: A2